亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Real‐world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

医学 心脏再同步化治疗 射血分数 内科学 心力衰竭 心脏病学 左束支阻滞 临床终点 植入式心律转复除颤器 心房颤动 加拿大心血管学会 生活质量(医疗保健) 临床试验 心肌梗塞 护理部 心绞痛
作者
Ignacio Garcı́a-Bolao,Roy S. Gardner,Daniel Gras,Antonio D’Onofrio,George E. Mark,Devi G. Nair,Nicolas Lellouche,Miroslav Novák,Ronald Lo,E. W. Chew,David J. Wright,Andrew J. Kaplan,Matteo Bertini,Sara Veraghtert,Michelle M. Harbin,Elizabeth Matznick,Patrick Yong,Kenneth M. Steín
出处
期刊:Esc Heart Failure [Wiley]
标识
DOI:10.1002/ehf2.15190
摘要

Abstract Aims Cardiac resynchronization therapy (CRT) is guideline recommended for the treatment of symptomatic heart failure (HF) with reduced left ventricular ejection fraction and prolonged QRS. However, patients with common comorbidities, such as persistent/permanent atrial fibrillation (AF), are often under‐represented in clinical trials. Methods The Strategic Management to Optimize Response to Cardiac Resynchronization Therapy (SMART) registry (NCT03075215) was a global, multicentre, registry that enrolled de novo CRT implants, or upgrade from pacemaker or implantable cardioverter defibrillator to CRT‐defibrillator (CRT‐D), using a quadripolar left ventricular lead in real‐world clinical practice. The primary endpoint was CRT response between baseline and 12 month follow‐up defined as a clinical composite score (CCS) consisting of all‐cause mortality, HF‐associated hospitalization, New York Heart Association (NYHA) class and quality of life global assessment. Results The registry enrolled 2035 patients, of which 1558 had completed CCS outcomes at 12 months. The patient cohort was 33.0% female, mean age at enrolment was 67.5 ± 10.4 years and the mean left ventricular ejection fraction was 29.6 ± 7.9%. Notably, there was a high prevalence of mildly symptomatic patients (NYHA class I/II 51.3%), non‐left bundle branch block (LBBB) morphology (38.0%), AF (37.2%) and diabetes mellitus (34.7%) at baseline. CCS at 12 months improved in 58.9% ( n = 917) of patients; 20.1% ( n = 313) of patients stabilized and 21.0% ( n = 328) worsened. Several patient characteristics were associated with a lower likelihood of response to CRT including older age, ischaemic aetiology, renal dysfunction, AF, non‐LBBB morphology and diabetes. Higher HF hospitalization ( P < 0.001) and all‐cause mortality ( P < 0.001) were observed in patients with AF. These patients also had lower percentages of ventricular pacing than patients in sinus rhythm at baseline and follow‐up ( P < 0.001, both). A further association between AF and non‐LBBB was observed with 81.4% of AF non‐LBBB patients experiencing an HF hospitalization compared with 92.5% of non‐AF LBBB patients (P < 0.001). Mortality between subgroups was also statistically significant ( P = 0.019). Conclusions This large, global registry enrolled a CRT‐D population with higher incidence of comorbidities that have been historically underrepresented in clinical trials and provides new insight into factors influencing response to CRT. As defined by CCS, 58.9% of patients improved and 20.1% stabilized. Patients with AF had particularly worse clinical outcomes, higher HF hospitalization and mortality rates and lower percentages of ventricular pacing. High incidence of HF hospitalization in patients with AF and non‐LBBB in this real‐world cohort suggests that ablation may play an important role in increasing future CRT response rates.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雨晨发布了新的文献求助10
1秒前
gqz发布了新的文献求助10
4秒前
小白加油完成签到 ,获得积分10
7秒前
含糊的千琴完成签到,获得积分10
9秒前
一花儿是小胖儿的完成签到,获得积分20
9秒前
Maestro_S的应助被gqz采纳,获得10
11秒前
11秒前
独特的海云完成签到 ,获得积分10
13秒前
段棋晔发布了新的文献求助10
15秒前
小李完成签到 ,获得积分10
19秒前
可爱的函函的应助被moriaty采纳,获得20
20秒前
24秒前
26秒前
雨晨完成签到,获得积分20
26秒前
27秒前
27秒前
sleepy发布了新的文献求助10
31秒前
九离完成签到,获得积分10
32秒前
labor完成签到,获得积分10
32秒前
33秒前
庾傀斗发布了新的文献求助10
34秒前
上官若男的应助被美满惜雪采纳,获得10
37秒前
Diamond完成签到 ,获得积分10
38秒前
庾傀斗发布了新的文献求助10
39秒前
jj发布了新的文献求助10
39秒前
整齐诺言完成签到,获得积分10
40秒前
41秒前
Bin_Liu完成签到,获得积分20
42秒前
滴滴答答完成签到 ,获得积分10
42秒前
43秒前
庾傀斗发布了新的文献求助10
44秒前
小羊完成签到,获得积分0
44秒前
45秒前
jj发布了新的文献求助10
46秒前
乐乐的应助被Jazz5688采纳,获得30
46秒前
聪慧哲瀚完成签到,获得积分10
47秒前
GingerF给芒果的求助进行了留言
49秒前
美满惜雪发布了新的文献求助10
50秒前
Nole的应助被露稚采纳,获得10
51秒前
笑点低的踏歌完成签到,获得积分20
53秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184945
求助须知:如何正确求助?哪些是违规求助? 9573899
关于积分的说明 21833591
捐赠科研通 7782403
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558672
邀请新用户注册赠送积分活动 2481161